rs104894544
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001614.5(ACTG1):c.353A>T(p.Lys118Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K118N) has been classified as Pathogenic.
Frequency
Consequence
NM_001614.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTG1 | NM_001614.5 | c.353A>T | p.Lys118Met | missense_variant | 3/6 | ENST00000573283.7 | NP_001605.1 | |
ACTG1 | NM_001199954.3 | c.353A>T | p.Lys118Met | missense_variant | 3/6 | NP_001186883.1 | ||
ACTG1 | NR_037688.3 | n.425A>T | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTG1 | ENST00000573283.7 | c.353A>T | p.Lys118Met | missense_variant | 3/6 | 5 | NM_001614.5 | ENSP00000458435 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 38
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 20 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2003 | - - |
Nonsyndromic genetic hearing loss Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | INGEBI, INGEBI / CONICET | Aug 18, 2021 | Based on ACMG/AMP guidelines and Hearing Loss Expert Panel specific criteria: the c.353A>T, p.(K118M) in ACTG1 gene is absent from population databases (PM2). This variant was identified in a family with autosomal dominant hearing loss and segregated with the eight affected members of it (PMID: 13680526). Besides, the c.353A>T was detected in other family with the same phenotype and it segregated with the six affected relatives (internal data, Laboratory of Physiology and Genetics of Hearing, CONICET Argentina) applying to PP1_Strong and PS4_Supporting rules. In addition to this, a different missense change in the same position which was functional validated (p.K118N; PMID: 19477959) was detected in a family case applying to PM5 criteria. Computational evidence predicted a pathogenic effect of the variant (Revel score: 0,957) meeting PP3 criteria. Considering all the evidence (PM2, PP1_Strong, PS4_Supporting, PM5 and PP3) the c.353A>T is classified as Pathogenic for non-syndromic autosomal dominant hearing loss. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2022 | Published functional studies performed in yeast and cultured mammalian cells suggest that this variant may alter actin function (Bryan et al., 2009; Morin et al., 2009; Kruth et al., 2012; Jepsen et al., 2016; Miyajima et al., 2020); Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27911912, 26832775, 25792668, 22718764, 13680526, 30599039, 32341388, 27463135, 19477959, 19419963, 34698053, 34997062) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at